SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-13-003663
Filing Date
2013-07-29
Accepted
2013-07-29 16:53:22
Documents
7
Period of Report
2013-07-25

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 3464
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 4486
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 487
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 671
5 GRAPHIC exhibit99-2x1x1.jpg GRAPHIC 115128
6 GRAPHIC exhibit99-3x1x1.jpg GRAPHIC 112810
7 GRAPHIC exhibit99-3x2x1.jpg GRAPHIC 9142
  Complete submission text file 0001062993-13-003663.txt   337481
Mailing Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1
Business Address 100 WELLINGTON ST. WEST SUITE 2110 P.O. BOX 151 TORONTO A6 M5K 1H1 416 593-3701
Merus Labs International Inc. (Filer) CIK: 0001031516 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 000-30082 | Film No.: 13993067
SIC: 2834 Pharmaceutical Preparations